This report on the global continuous renal replacement therapy market analyzes the current and future scenario of the global market
Albany, NY -- (SBWIRE) -- 05/08/2018 -- In order to study the various trends and patterns prevailing in the overall market for continuous renal replacement therapy, Market Research Reports Search Engine (MRRSE) has included a new report titled "Global Continuous Renal Replacement Therapy Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Readers can access the regional as well as segment-wise analysis for acquiring precise information about the global market structure.
Get Inside Scoop of Sample Report @ https://www.mrrse.com/sample/4768
Continuous renal replacement therapy (CRRT) is used to treat acute kidney injury of critically ill patients admitted in the intensive care unit. Patients with acute renal failure along with complications such as imperfections or multiple organ failure in their circulatory system or cardiac that include edema and cardiac insufficiency are also treated by the use of CRRT. The other complications for which CRRT is used include postoperative liver failure, fulminant hepatitis, serve acute pancreatitis, and multiple organ failure. In 2016, continuous renal replacement therapy was valued at nearly US$ 700.0 Mn and is anticipated to register a CAGR of over 6.5% from 2017 to 2025 to reach value of approximately over US$ 1000 Mn by 2025. Increasing number of dialysis centers across the world is likely to fuel expansion of continuous renal replacement therapy from 2017 to 2025.
In CRRT, the fluid status of the patients is controlled with the help of an electrolyte solution the patient's blood is cleaned, the uremic toxins are removed, acid-base abnormalities, and electrolyte are corrected, and extracorporeal blood circuit is required. Increasing prevalence of acute kidney injury drives the expansion of the market from 2017 to 2025. The sudden failure of kidney due to various indications leads to acute kidney injury. All over the world, every year approximately 3 million end-stage renal disease patients, and 470,000 end-stage renal disease patients in the U.S. are dependent on life-sustaining dialysis treatment. In the next 10 years, the number of patients is anticipated to double. According to U.S. data, 5% to 20% experience acute kidney injury during their course of illness in the ICU, and as acute kidney injury develops, there is a huge negative impact on outcomes of any illness.
The global continuous renal replacement therapy market has been classified on the basis of mode, product, therapy, end-user, and region. Based on mode, the market has been categorized into slow continuous ultrafiltration, continuous veno-venous haemo-filtration, continuous veno-venous haemo-dialysis, and continuous veno-venous haemo-dia-filtration. Among these, continuous veno-venous haemo-filtration segment leads the market and is expected to continue its dominance during the forecast period followed by continuous veno- venous haemo-dialysis. The high market share of continuous veno-venous haemo-filtration segment is attributed due to CVVH is more effective than continuous veno-venous haemo-dia-filtration (CVVHDF), and may be associated with fewer complications.
For More Information About This Report Visit at: https://www.mrrse.com/continuous-renal-replacement-therapy-report
The report also profiles major players in the global continuous renal replacement therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., and other prominent players.
The global continuous renal replacement therapy market has been segmented as below:
Global continuous renal replacement therapy market, by mode
Slow Continuous Ultra filtration
Continuous Veno Venous Haemo-filtration
Continuous Veno Venous Haemo-dialysis
Continuous Veno Venous Haemo-diafiltration
Global continuous renal replacement therapy market, by product
Dialysate and Replacement Fluids
Global continuous renal replacement therapy market, by therapy
Combination of Both
Global continuous renal replacement therapy market, by end-user
Global continuous renal replacement therapy market, by geography
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Any Query or Specific Requirement? Ask to our Expert @ https://www.mrrse.com/enquiry/4768
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207
United States Telephone: +1-518-730-0559